- Home
- NEUE vs ANEB Comparison
NEUE vs ANEB Comparison
Compare NEUE & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUE
- ANEB
- Stock Information
- Founded
- NEUE 2015
- ANEB 2020
- Country
- NEUE United States
- ANEB United States
- Employees
- NEUE N/A
- ANEB N/A
- Industry
- NEUE
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- NEUE
- ANEB Health Care
- Exchange
- NEUE NYSE
- ANEB Nasdaq
- Market Cap
- NEUE 41.6M
- ANEB 41.2M
- IPO Year
- NEUE 2021
- ANEB 2021
- Fundamental
- Price
- NEUE $5.00
- ANEB $1.59
- Analyst Decision
- NEUE Hold
- ANEB Buy
- Analyst Count
- NEUE 1
- ANEB 1
- Target Price
- NEUE $8.00
- ANEB $8.00
- AVG Volume (30 Days)
- NEUE 8.7K
- ANEB 5.5K
- Earning Date
- NEUE 11-07-2024
- ANEB 11-13-2024
- Dividend Yield
- NEUE N/A
- ANEB N/A
- EPS Growth
- NEUE N/A
- ANEB N/A
- EPS
- NEUE N/A
- ANEB N/A
- Revenue
- NEUE $996,890,000.00
- ANEB N/A
- Revenue This Year
- NEUE N/A
- ANEB N/A
- Revenue Next Year
- NEUE $10.49
- ANEB N/A
- P/E Ratio
- NEUE $1.47
- ANEB N/A
- Revenue Growth
- NEUE N/A
- ANEB N/A
- 52 Week Low
- NEUE $4.66
- ANEB $1.46
- 52 Week High
- NEUE $16.59
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- NEUE 46.19
- ANEB 41.55
- Support Level
- NEUE $4.66
- ANEB $1.46
- Resistance Level
- NEUE $5.24
- ANEB $1.73
- Average True Range (ATR)
- NEUE 0.34
- ANEB 0.11
- MACD
- NEUE -0.01
- ANEB -0.02
- Stochastic Oscillator
- NEUE 39.53
- ANEB 26.20
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.